The United States Continuous Glucose Monitoring (CGM) was valued at $3.5 billion in 2024 and is expected to grow at a CAGR of 12.5% in the forecast period, to reach $7.5 billion by 2033.

A comprehensive study of the whole US continuous glucose monitoring industry is included in this new 2025 market report. The report provides the most recent industry data on the current state of the market and its prospects for the continuous glucose monitoring market in the United States. The study covers important market features such as market value, volume analysis, and trends for continuous glucose monitoring (CGM) in the US. It also offers current historical market size data for the years 2021–2024 and an illustrative projection to 2033. Continuous glucose monitoring systems have undergone a thorough comparative investigation.

The market size, CGM volume, revenues, and an illustrative projection for 2033 are all disclosed in this new 2025 market study, which also provides a detailed analysis of current industry conditions and market demands. An overview of the total number of diabetic patients and insulin users in the US is also included in the report. The pricing, demand, and major developments of the US market for continuous glucose monitoring have all been thoroughly examined. Facts, figures, growth rate, and demand for the continuous glucose monitoring versus blood glucose meter market in the US are also disclosed in the report.

This current study also provides a comprehensive perspective of the regulatory framework of the continuous glucose monitoring market in the United States and discusses the most recent aspects of reimbursement trends. Important trends in partnership and collaboration agreements are thoroughly examined. The research also provides a thorough analysis of the changing industry trends and factors that propel and hinder the expansion of the continuous glucose monitoring market in the US.

Along with information on corporate overviews, product portfolios, and the most recent advancements, the study also examines in-depth profiles of prominent and inventive businesses. Innovative technology-based continuous glucose monitoring is being made by other up-and-coming businesses, which is anticipated to disrupt market share throughout the course of the projection period.

The report will be used as a reference for a comprehensive 360-degree examination that integrates many models.

This Newest and Comprehensive United States Continuous Glucose Monitoring (CGM) Market Research Report 2025 Delivers:

  • Comprehensive Research Methodology of the United States Continuous Glucose Monitoring (CGM) Market
  • Detailed and Extensive Market Overview with Key Analyst Insights
  • Insights about Market Determinants that are Stimulating the United States Continuous Glucose Monitoring (CGM) Market
  • To Analyze the Historical Growth in the Market Size of the United States Continuous Glucose Monitoring (CGM) Market from 2021 to 2024
  • To Estimate and Forecast the Market Size of the United States Continuous Glucose Monitoring (CGM) from 2022 to 2028 and Growth Rate until 2033
  • Detailed Assessment of the United States Continuous Glucose Monitoring (CGM) Users Volume and Forecast to 2033
  • Thorough Assessment of the United States Continuous Glucose Monitoring (CGM) Vs Blood Glucose Meter (BGM) Market Size and Growth Rate (2021–2033)
  • Delivers Comprehensive Insights on the Continuous Glucose Monitoring Devices Comparative Analysis
  • An Insightful Analysis of the United States Diabetes Population and Forecast to 2033
  • Delivers a Complete Overview of the United States Insulin Users and Forecast to 2033
  • Delivers Comprehensive Insights into the Regulatory Framework of the United States Continuous Glucose Monitoring (CGM) Market
  • Features and Reimbursement Patterns of the United States Continuous Glucose Monitoring (CGM) Market
  • Delivers an In-Depth Analysis of Evolving Market Trends, Drivers, and Restraints of the United States Continuous Glucose Monitoring (CGM) Market
  • Tracks Competitive Developments, Approaches, Recent Industry Developments, Collaboration Deals, and Partnership Deals
  • A Comprehensive List of the Leading Companies along with the Analysis of their Current Product Portfolios, Business Overview, and Current Development

The Key Market Players for the United States Continuous Glucose Monitoring (CGM) Market are Listed Below:

  • Abbott
  • Dexcom, Inc.
  • Medtronic, Inc.
  • Senseonics Holdings, Inc.

The Report Helps Answer the Following Questions:

  • What is the current scenario of the United States’ continuous glucose monitoring?
  • What is the total market size and forecast (until 2028) of the United States continuous glucose monitoring?
  • How big is the United States continuous glucose monitoring market?
  • At what CAGR is the U.S. continuous glucose monitoring market projected to grow in the forecast period (2022-2028)?
  • What is the regulatory framework in the United States continuous glucose monitoring market?
  • How much do continuous glucose monitors cost?
  • What is the reimbursement pattern in the United States Continuous Glucose Monitoring (CGM) market?
  • Which companies make continuous glucose monitors?
  • What are the key factors driving the United States’ continuous glucose monitoring market?
  • What are the key challenges of the United States’ continuous glucose monitoring market?
  • What are the major deals and agreements happening in the United States continuous glucose monitoring market?
  • What are the various continuous glucose monitoring options available in the United States?
  • Who are the topmost market players? What are their happenings, current developments, and scenarios?
  • How is the market predicted to develop in the future?